openPR Logo
Press release

Continuous Glucose Monitoring Systems Market Registering A CAGR Of 22.9% By 2024

06-12-2018 07:56 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Research Beam Market

Continuous Glucose Monitoring Systems Market Registering

Continuous glucose monitoring (CGM) is one of the latest technological advancements in the field of diabetes management. CGM system is a type of glucose monitoring device that functions by inserting a biosensor through transcutaneous or subcutaneous route. The embedded sensor measures the glucose levels in interstitial fluid or blood, and transmits the information using a transmitter to a receiver/monitor for displaying the results. These systems play an integral role in diabetes management, owing to their associated several advantages over other glucose monitoring devices. Unlike conventional glucose monitors, these systems enable periodic monitoring of glucose levels, which is crucial for avoiding diabetic complications. In addition, CGMS technology has laid a roadmap to the most awaited, high-tech, closed-loop artificial/bionic pancreas. Therefore, development of novel and technologically advanced CGMS is the prime focus of glucose monitoring device manufacturing companies. It offers a wide range of applications for all age-cohorts, healthcare settings (diagnostic centers/clinics, hospital ICUs, and home healthcare), and geographies. Thus, CGMS market poses lucrative opportunity for both CGMS manufacturers and insulin pump manufacturers.

For More Info, Get Sample : https://www.researchbeam.com/continuous-glucose-monitoring-systems-market/request-sample

The global CGMS market generated $894 million in 2016, and is projected to reach $4,921 million by 2024, registering a CAGR of 22.9% during the forecast period. The pipeline of high-tech CGMS devices, such as smartphone-connected CGMS, wearable & smartphone-connected CGMS, non-invasive CGMS and ‘smart’ diabetes management solution (also called artificial/bionic pancreas), is expected to result in higher adoption of CGMS among endocrinologists and patients.

The market is categorized based on component, demographics, end user, and region. The CGMS components market includes durable components such as transmitters & receivers and integrated insulin pumps; and disposable components such as sensors. The segment for sensors occupies a dominant share in the CGMS market due to recurring sales of CGMS, short scrap life, and bulk purchases. Therefore, it is deployed in diagnostic centers/clinics. Moreover, the adoption of CGMS in hospital ICUs and in-home healthcare settings has increased in the recent years. On the basis of demographics, CGMS devices are categorized into child population (≤14 years) and adult population (>14 years).

The report includes comprehensive geographical analysis and segmentation of geographical regions, which include North America, Europe, Asia-Pacific, and LAMEA. The major strategies adopted by market players are collaborations, product launches, and product approvals. The adoption of collaboration strategy by companies enables greater focus on innovation, distribution, and commercialization of devices.

KEY BENEFITS

• This report provides an extensive analysis of the current and emerging trends, and dynamics in the global CGMS market to identify the prevailing opportunities.
• It presents a competitive landscape of the global market to predict the market scenario across geographies.
• A comprehensive analysis of factors that drive and restrict the market growth is provided.
• The region- and country-wise analyses are provided to understand the market trends and dynamics.

KEY MARKET SEGMENTS

Enquire About Report : https://www.researchbeam.com/continuous-glucose-monitoring-systems-market/enquire-about-report

By Component

• Sensors
• Transmitters & Receivers
• Integrated Insulin Pumps

By Demographics

• Child Population (≤14 years)
• Adult Population (>14 years)

By End User

• Diagnostics & Clinics
• ICUs
• Home Healthcare

By Region

• NORTH AMERICA
• U.S.
• CANADA
• MEXICO
• EUROPE
• GERMANY
• FRANCE
• UK
• ITALY
• SPAIN
• NETHERLANDS
• NORWAY
• SWEDEN
• DENMARK
• FINLAND
• REST OF EUROPE
• ASIA-PACIFIC
• JAPAN
• CHINA
• INDIA
• AUSTRALIA
• SOUTH KOREA
• REST OF ASIA-PACIFIC
• LAMEA
• BRAZIL
• SAUDI ARABIA
• SOUTH AFRICA
• VENEZUELA
• ARGENTINA
• Rest of LAMEA

Also Request For Discount : https://www.researchbeam.com/continuous-glucose-monitoring-systems-market/purchase-enquiry

The key players profiled in this report are as follows:

• Abbott Laboratories
• Dexcom, Inc.
• Menarini Diagnostics
• Echo Therapeutics, Inc.
• GlySens Incorporated
• Johnson & Johnson
• Insulet Corporation
• Medtronic plc
• Senseonics Holdings, Inc.
• F. Hoffmann-La Roche Ltd.

Table Of Content

• CHAPTER 1: INTRODUCTION
• CHAPTER 2: EXECUTIVE SUMMARY
• CHAPTER 3: MARKET OVERVIEW
• CHAPTER 4: CONTINOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT
• CHAPTER 5: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS
• CHAPTER 6: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER
• CHAPTER 7: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION
• CHAPTER 8: COMPANY PROFILES

About Us
We have a large database of quality and precise market research reports that will be very beneficial for your organization. Reports that we sell our authentic in nature and from reputed publishers, hence it can definitely help you with your growth opportunities. Research Beam will always make sure to bring most ethical and high quality reports. We value your relationship with us and look forward for a long term relation.

Contact Us
Global Head Quarters
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
+1 (800) 910-6452
help@researchbeam.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Continuous Glucose Monitoring Systems Market Registering A CAGR Of 22.9% By 2024 here

News-ID: 1078173 • Views: 581

More Releases from Research Beam Market

Blood Plasma Derivatives Market Growing With $44,333 Million At A CAGR of 9.3% From 2017 To 2023.
Blood Plasma Derivatives Market Growing With $44,333 Million At A CAGR of 9.3% F …
Blood plasma is liquid component of blood where the blood cells are suspended. It contains dissolved proteins (albumins, globulins, and fibrinogen), clotting factors, hormones, and electrolytes. Plasma maintains the blood pressure and helps in exchange of important minerals such as sodium and potassium to maintain the pH balance in the body. Plasma derivatives are products that are manufactured from human plasma by plasma fractionation techniques. These derivatives include albumin, factor
Holter ECG Monitoring Market Growing $418.3 Million By 2023
Holter ECG Monitoring Market Growing $418.3 Million By 2023
Holter monitors are devices that allow prolonged monitoring of heart rhythm from a few days to several months, enabling the detection of infrequent arrhythmias in patients. In addition, holter monitors help identify ventricular tachycardia (VT) in patients with recognized risk of sudden cardiac death. Portability of holter monitors significantly propel the market growth as they can be easily worn by the patients to record heart activity for a certain period
Intermittent Catheters Market Reach $2,950.7 Million By 2023
Intermittent Catheters Market Reach $2,950.7 Million By 2023
The global intermittent catheters market was valued at $1,655.5 million in 2016, and is expected to reach $2,950.7 million by 2023 with a CAGR of 8.7% during the forecast period. Intermittent catheter is a disposable medical device, which is used to drain the urinary bladder when an individual is unable to do it naturally. Intermittent catheter consists of a drainage bag that assists to capture the urine. These catheters are
Cartilage Repair Market, Registering A CAGR Of 15.0% From 2018 To 2025.
Cartilage Repair Market, Registering A CAGR Of 15.0% From 2018 To 2025.
Articular cartilage is a complex tissue, which is devoid of blood supply (avascular). It is composed of distinct cells called chondrocytes suspended in a collagenous matrix. The key function of this tissue is to smoothen bone movements, and absorbs shock along with providing cushioning to the joints. For More Info, Get Sample : https://www.researchbeam.com/cartilage-repair-market/request-sample Cartilage repair is a type of cartilage restoration method, wherein

All 5 Releases


More Releases for CGM

Continuous Glucose Monitoring (CGM) Devices Market Higher convenience offered by …
The CGM displays a glucose trend graph and direction arrows allowing people with diabetes to anticipate approaching glucose highs and lows, thus alerting the wearer during distracted times like playing, sleeping or exercising. The CGM devices market is expected to gain a significant traction in Asia Pacific owing to the collaborations between endocrinologists, credentialed diabetes educators and stakeholder organizations for diabetes prevention. In 2017, National Diabetes Services Scheme (NDSS) initiated by
Global Continuous Glucose Monitoring Devices (CGM) Market
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Continuous Glucose Monitoring Device Market. The report analyzes the Global Continuous Glucose Monitoring Market by Component (Transmitter & receiver, sensor, Integrated Insulin Pump), By Demographics (Pediatric, Adult), By End user (Homecare, Hospital), By Region (North America, Europe, Asia Pacific, Rest of the world)
Canada Insulin Pump & CGM Industry 2018
Canada Insulin Pump & CGM Industry Although Canada insulin pump market is small but it has market potential to reach nearly CAD 1 Billion mark by the end of year 2024. Similarly CGM market is also small but if it gets reimbursement under Canadian government then it has market potential to surpass CAD 80 Million by 2024. The government of Canada has expanded its diabetes management policy along with diabetes technology which will
Global CGM Market, Users, Reimbursement Policy, CGM Components (Glucose Sensor, …
To study the market for CGM market in a precise manner, Market Research Hub (MRH) has included a new research report. The report is titled “Global CGM Market, Users, Reimbursement Policy, CGM Components (Glucose Sensor, Transmitter) Market, Diabetes (Type1 & 2) Population, & Forecast”, which enlightens the readers about the market share as well as growth rate during the period 2017-2022. The research study estimates that the CGM market sector
Global CGM Market, Users, Reimbursement Policy, CGM Components (Glucose Sensor, …
"The Report Global CGM Market, Users, Reimbursement Policy, CGM Components (Glucose Sensor, Transmitter) Market, Diabetes (Type1 & 2) Population, & Forecast provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Global CGM market will be an US$ 4 Billion opportunity by 2024. This report provides the market data on, continuous glucose monitoring (CGM) systems market of 11 countries globally. In the report CGM
Global CGM Market, Users, Reimbursement Policy, CGM Components (Glucose Sensor, …
Researchmoz added Most up-to-date research on "Global CGM Market, Users, Reimbursement Policy, CGM Components (Glucose Sensor, Transmitter) Market, Diabetes (Type1 & 2) Population, & Forecast" to its huge collection of research reports. Global CGM market will be an US$ 4 Billion opportunity by 2024. This report provides the market data on, continuous glucose monitoring (CGM) systems market of 11 countries globally. In the report CGM market has been divided into 2